{Reference Type}: Journal Article
{Title}: The path via pathway-based approaches towards safety assessment: A concise review.
{Author}: Jin Y;Qi G;Feng M;Yu D;Jin Y;Qi G;Feng M;Yu D;Jin Y;Qi G;Feng M;Yu D;
{Journal}: Toxicol Appl Pharmacol
{Volume}: 452
{Issue}: 0
{Year}: Oct 2022 1
{Factor}: 4.46
{DOI}: 10.1016/j.taap.2022.116195
{Abstract}: For decades, chemical safety assessment has been proposed to shift from animal testing to in vitro testing systems in response to the call for the 3R. In Europe, the answer was to combine various information sources in integrated testing strategies (ITS); In the US, it was in 2007 when the landmark report by the National Research Council put forward a vision of in vitro toxicity testing paradigm. Since then, efforts to develop pathway-based assessment framework have been on the track. In 2010, systems biology brought out a conceptual framework called adverse outcome pathway (AOP), which took one step further from toxicity pathway to regulatory toxicology. Computational modeling, high-throughput screening, high-content omics have all been approached to facilitate this progress. This paper briefly reviewed the achievement of pathway-based chemical assessment since 2007, discussed potential pitfalls and challenges that mechanism-driven chemical assessment may undergo, and presented future perspectives of safety assessment that is to be based on computational system biology.